NCT07551999 A Study Of Remote Voice Analysis Tool For Diagnosing And Monitoring ME/CFS
| NCT ID | NCT07551999 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Encephalomyelitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-05-26 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2026-05-26 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research is to evaluate the use of a voice-based tool in the diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Eligibility Criteria
Inclusion Criteria: * Diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) verified by an ME/CFS specialist. * Ability to complete study questionnaires and provide voice samples using a smartphone application. * Consistent access to a smartphone or tablet with iOS or Android operating systems, or a laptop. Exclusion Criteria: * No diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); "Chronic Fatigue Syndrome" not verified by an ME/CFS specialist. * Lack of consistent access to a smartphone or tablet with iOS or Android operating systems, or laptop. * Known dementia or other neurodegenerative disorder prominently affecting cognition or speech patterns. outside of ME/CFS * Known history of voice disorder either primary or secondary to neuromuscular or other pathology outside of ME/CFS * Known clinically significant heart failure or greater than moderate pulmonary hypertension.
Contact & Investigator
Stephanie L. Grach, MD, MS
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT07551999 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Encephalomyelitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07551999 currently recruiting?
Yes, NCT07551999 is actively recruiting participants. Contact the research team at Cruz.Katie@mayo.edu for enrollment information.
Where is the NCT07551999 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT07551999 clinical trial?
NCT07551999 is sponsored by Mayo Clinic. The principal investigator is Stephanie L. Grach, MD, MS at Mayo Clinic. The trial plans to enroll 40 participants.